Karamfilova, Vera, et al. “Fibroblast Growth Factor 21 As a Marker of Prediabetes in Patients With Non-Alcoholic Fatty Liver Disease”. Turkish Journal of Gastroenterology, vol. 33, no. 3, Jan. 2022, pp. 233-9, doi:10.5152/tjg.2021.201165.